These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34893384)

  • 1. Treatment of Hypophonia in Parkinson's Disease Through Biofeedback in Daily Life Administered with A Portable Voice Accumulator.
    Gustafsson JK; Södersten M; Ternström S; Schalling E
    J Voice; 2024 May; 38(3):800.e27-800.e38. PubMed ID: 34893384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tactile biofeedback by a portable voice accumulator on voice sound level in speakers with Parkinson's disease.
    Schalling E; Gustafsson J; Ternström S; Bulukin Wilén F; Södersten M
    J Voice; 2013 Nov; 27(6):729-37. PubMed ID: 24050819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor-Learning-Based Adjustment of Ambulatory Feedback on Vocal Loudness for Patients With Parkinson's Disease.
    Gustafsson J; Ternström S; Södersten M; Schalling E
    J Voice; 2016 Jul; 30(4):407-15. PubMed ID: 26168903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Portable Voice Accumulators to Study Transfer of Speech Outcomes Following Intervention - A Feasibility Study.
    Steurer H; Körner Gustafsson J; Franzén E; Schalling E
    J Voice; 2024 Jul; 38(4):965.e1-965.e13. PubMed ID: 34852954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of Lee Silverman Voice Treatment on daily voice use in Parkinson's disease as measured with a portable voice accumulator.
    Körner Gustafsson J; Södersten M; Ternström S; Schalling E
    Logoped Phoniatr Vocol; 2019 Oct; 44(3):124-133. PubMed ID: 29447488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voice Use in Daily Life Studied With a Portable Voice Accumulator in Individuals With Parkinson's Disease and Matched Healthy Controls.
    Gustafsson JK; Södersten M; Ternström S; Schalling E
    J Speech Lang Hear Res; 2019 Dec; 62(12):4324-4334. PubMed ID: 31830844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
    Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
    Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of increased vocal intensity on interarticulator timing in speakers with Parkinson’s disease: a preliminary analysis.
    Richardson K; Sussman JE; Stathopoulos ET
    J Commun Disord; 2014; 52():44-64. PubMed ID: 25459460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectral/Cepstral Analyses of Phonation in Parkinson's Disease before and after Voice Treatment: A Preliminary Study.
    Alharbi GG; Cannito MP; Buder EH; Awan SN
    Folia Phoniatr Logop; 2019; 71(5-6):275-285. PubMed ID: 31117110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship Between Voice and Motor Disabilities of Parkinson's Disease.
    Majdinasab F; Karkheiran S; Soltani M; Moradi N; Shahidi G
    J Voice; 2016 Nov; 30(6):768.e17-768.e22. PubMed ID: 26725551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lee Silverman Voice Treatment for people with Parkinson's: audit of outcomes in a routine clinic.
    Wight S; Miller N
    Int J Lang Commun Disord; 2015; 50(2):215-25. PubMed ID: 25469736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of group voice therapy for individuals with Parkinson's disease.
    Searl J; Wilson K; Haring K; Dietsch A; Lyons K; Pahwa R
    J Commun Disord; 2011; 44(6):719-32. PubMed ID: 21889774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of vocal symptoms in Parkinson's disease: the Lee Silverman method].
    Dias AE; Limongi JC
    Arq Neuropsiquiatr; 2003 Mar; 61(1):61-6. PubMed ID: 12715021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Voice Use in Patients With Voice Disorders and Vocally Healthy Speakers Based on 2 Days Voice Accumulator Information From a Database.
    Södersten M; Salomão GL; McAllister A; Ternström S
    J Voice; 2015 Sep; 29(5):646.e1-9. PubMed ID: 26073776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's disease.
    Rusz J; Cmejla R; Ruzickova H; Ruzicka E
    J Acoust Soc Am; 2011 Jan; 129(1):350-67. PubMed ID: 21303016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voice Tremor Outcomes of Subthalamic Nucleus and Zona Incerta Deep Brain Stimulation in Patients With Parkinson Disease.
    Karlsson F; Malinova E; Olofsson K; Blomstedt P; Linder J; Nordh E
    J Voice; 2019 Jul; 33(4):545-549. PubMed ID: 29361338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can the Lombard effect be used to improve low voice intensity in Parkinson's disease?
    Adams SG; Lang AE
    Eur J Disord Commun; 1992; 27(2):121-7. PubMed ID: 1446099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biofeedback on voice use in call center agents in order to prevent occupational voice disorders.
    Schneider-Stickler B; Knell C; Aichstill B; Jocher W
    J Voice; 2012 Jan; 26(1):51-62. PubMed ID: 21429709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily Phonatory Activity of Individuals With Parkinson's Disease.
    Searl J; Dietsch AM
    J Voice; 2024 May; 38(3):800.e13-800.e26. PubMed ID: 34819239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perception of Physical Demand, Mental Demand, and Performance: A Comparison of Two Voice Interventions for Parkinson's Disease.
    Richardson K; Huber JE; Kiefer B; Snyder S
    Am J Speech Lang Pathol; 2022 Sep; 31(5):1963-1978. PubMed ID: 35858264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.